Z. Alexander Cao
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 12
- Colorectal Cancer Treatments and Studies 11
- Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 10
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 7
- Immunology top 5%
-
- Gastric Cancer Management and Outcomes 9
- Lung Cancer Treatments and Mutations 4
-
- Esophageal Cancer Research and Treatment 4
-
- Radiomics and Machine Learning in Medical Imaging 3
- Co-authors
- Ray McDermottScott KopetzMichael J. OvermanRebecca A. MossThierry AndréSara LonardiHeinz‐Josef LenzAndrew Hill
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Z. Alexander Cao
37 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 3.7k
- Pathology and Forensic Medicine 1.4k
- Cancer Research 769
- Immunology 860
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Z. Alexander Cao
This map shows the geographic impact of Z. Alexander Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Alexander Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Alexander Cao more than expected).
Fields of papers citing papers by Z. Alexander Cao
This network shows the impact of papers produced by Z. Alexander Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Alexander Cao. The network helps show where Z. Alexander Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Z. Alexander Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 24 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 19 | |
| 8 | 2022 | 55 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 39 | |
| 11 | 2021 | 42 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 4 | |
| 14 | Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancerbreakdown → | 2018 | 1429 |
| 15 | 2018 | 8 | |
| 16 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studybreakdown → | 2017 | 1977 |
| 17 | 2017 | 15 | |
| 18 | 2017 | 24 | |
| 19 | 2017 | 58 | |
| 20 | CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitorsbreakdown → | 2014 | 351 |
About Z. Alexander Cao
Z. Alexander Cao is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research, having authored 40 papers that have together received 4.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (10 papers), Gastric Cancer Management and Outcomes (9 papers), Cancer Genomics and Diagnostics (7 papers), Esophageal Cancer Research and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). The work is most often cited by research in Oncology (3.7k citations), Pathology and Forensic Medicine (1.4k citations) and Cancer Research (769 citations). Z. Alexander Cao has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Ray McDermott, Scott Kopetz, Michael J. Overman, Rebecca A. Moss, Thierry André, Sara Lonardi, Heinz‐Josef Lenz, Andrew Hill, Jean-Marie Ledeine and Michael A. Morse. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.